84 related articles for article (PubMed ID: 8587588)
21. Funding support lacking in search for HIV vaccine.
AIDS Alert; 1999 Jan; 14(1):5-7. PubMed ID: 11366091
[TBL] [Abstract][Full Text] [Related]
22. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
Emini EA; Koff WC
Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
[No Abstract] [Full Text] [Related]
23. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.
Karnasuta C; Paris RM; Cox JH; Nitayaphan S; Pitisuttithum P; Thongcharoen P; Brown AE; Gurunathan S; Tartaglia J; Heyward WL; McNeil JG; Birx DL; de Souza MS;
Vaccine; 2005 Mar; 23(19):2522-9. PubMed ID: 15752839
[TBL] [Abstract][Full Text] [Related]
24. Vaccine to prevent AIDS overstated.
Lewis D
Res Initiat Treat Action; 1999 Jan; 5(1):11-2. PubMed ID: 11366223
[TBL] [Abstract][Full Text] [Related]
25. Vaccine development moves to front burner.
AIDS Alert; 1997 Mar; 12(3):32-3. PubMed ID: 11364191
[TBL] [Abstract][Full Text] [Related]
26. First human efficacy trial of AIDS vaccine in developing country.
CVI Newswatch; 1999 May; (1):2. PubMed ID: 12295316
[TBL] [Abstract][Full Text] [Related]
27. Prime-boost immunization strategies against HIV.
Barnett SW; Klinger JM; Doe B; Walker CM; Hansen L; Duliège AM; Sinangil FM
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S299-309. PubMed ID: 9814958
[No Abstract] [Full Text] [Related]
28. AIDSVAX is safe, but efficacy question remains. VaxGen founder discusses quest for AIDS vaccine.
Francis DP
AIDS Alert; 2001 Nov; 16(11):141-2, 147. PubMed ID: 11692665
[No Abstract] [Full Text] [Related]
29. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
30. Honing the immune attack on HIV.
Gilden D
GMHC Treat Issues; 1996 Dec; 10(12):8-11. PubMed ID: 11364019
[TBL] [Abstract][Full Text] [Related]
31. AIDS research. Debate begins over new vaccine trials.
Cohen J
Science; 2001 Sep; 293(5537):1973. PubMed ID: 11557856
[No Abstract] [Full Text] [Related]
32. Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators.
Borkowsky W; Wara D; Fenton T; McNamara J; Kang M; Mofenson L; McFarland E; Cunningham C; Duliege AM; Francis D; Bryson Y; Burchett S; Spector SA; Frenkel LM; Starr S; Van Dyke R; Jimenez E
J Infect Dis; 2000 Mar; 181(3):890-6. PubMed ID: 10720509
[TBL] [Abstract][Full Text] [Related]
33. Recombination property of the HIV-1 gp120 gene.
Prljic J; Veljkovic N; Veljkovic V
Int Rev Immunol; 2004; 23(5-6):447-54. PubMed ID: 15370276
[TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.
McFarland EJ; Borkowsky W; Fenton T; Wara D; McNamara J; Samson P; Kang M; Mofenson L; Cunningham C; Duliege AM; Sinangil F; Spector SA; Jimenez E; Bryson Y; Burchett S; Frenkel LM; Yogev R; Gigliotti F; Luzuriaga K; Livingston RA;
J Infect Dis; 2001 Nov; 184(10):1331-5. PubMed ID: 11679925
[TBL] [Abstract][Full Text] [Related]
35. Safety and ethical consideration of AIDS vaccine.
Veljkovic V; Prljic J; Veljkovic T
Int Rev Immunol; 2004; 23(5-6):465-86. PubMed ID: 15370278
[TBL] [Abstract][Full Text] [Related]
36. AIDS vaccines: back to 'plan A'.
Check E
Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164
[No Abstract] [Full Text] [Related]
37. Risk behaviours and comprehension among intravenous drug users volunteered for HIV vaccine trial.
Pitisuttithum P; Migasena S; Laothai A; Suntharasamai P; Kumpong C; Vanichseni S
J Med Assoc Thai; 1997 Jan; 80(1):47-50. PubMed ID: 9078816
[TBL] [Abstract][Full Text] [Related]
38. Vaccine trial in Thailand.
AIDS Patient Care STDS; 1999 Jun; 13(6):377. PubMed ID: 10842863
[No Abstract] [Full Text] [Related]
39. Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and Thailand.
Berman PW; Huang W; Riddle L; Gray AM; Wrin T; Vennari J; Johnson A; Klaussen M; Prashad H; Köhne C; deWit C; Gregory TJ
Virology; 1999 Dec; 265(1):1-9. PubMed ID: 10603312
[TBL] [Abstract][Full Text] [Related]
40. AIDS-vaccine firm needled by stock-exchange rules.
Nature; 2004 May; 429(6990):335. PubMed ID: 15164031
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
